Catalyst Pharmaceuticals
CPRX
#3828
Rank
NZ$4.58 B
Marketcap
$38.41
Share price
1.94%
Change (1 day)
69.15%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): NZ$0.30 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.46 Billion. In 2023 the company made an earning of NZ$0.16 Billion a decrease over its 2022 earnings that were of NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.30 B85.01%
2023 NZ$0.16 B-9.75%
2022 NZ$0.18 B98.83%
2021 NZ$91.65 M25.73%
2020 NZ$72.89 M25.38%
2019 NZ$58.13 M-198.25%
2018 -NZ$59.18 Million84.68%
2017 -NZ$32.05 Million1.88%
2016 -NZ$31.45 Million-10.68%
2015 -NZ$35.21 Million30.46%
2014 -NZ$26.99 Million27.6%
2013 -NZ$21.16 Million198.17%
2012 -NZ$7.1 Million-36.22%
2011 -NZ$11.13 Million59.52%
2010 -NZ$6.98 Million-44.68%
2009 -NZ$12.61 Million-31.45%
2008 -NZ$18.39 Million155.21%
2007 -NZ$7.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.68 B 107.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.22 B-31.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.01 B 9,643.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.48 Billion-243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.08 B 3,577.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.79 B 3,490.25%๐Ÿ‡บ๐Ÿ‡ธ USA